The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary Vaccine Adjuvants Market Research Report 2024
Synopsis
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The global Veterinary Vaccine Adjuvants market was valued at US$ 303.7 million in 2023 and is anticipated to reach US$ 485.1 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%. Among them, SEPPIC is the leader with about 35% market share.
North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%. In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%. And in terms of application, the largest application is Livestock Vaccines, followed by Companion Animals Vaccines.
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine Adjuvants.
Report Scope
The Veterinary Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SEPPIC
SDA BIO
Croda
SPI Pharma
Phibro Animal Health
Vertellus
Segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Segment by Application
Livestock Vaccines
Companion Animals Vaccines
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The global Veterinary Vaccine Adjuvants market was valued at US$ 303.7 million in 2023 and is anticipated to reach US$ 485.1 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Global 5 largest manufacturers of Veterinary Vaccine Adjuvants are SEPPIC, Croda, Vertellus, SPI Pharma and SDA BIO, which make up about 70%. Among them, SEPPIC is the leader with about 35% market share.
North America is the largest market, with a share over 30%, followed by Asia-Pacific and Europe, with the share about 30% and 22%. In terms of product type, Emulsion Adjuvants occupy the largest share of the total market, about 58%. And in terms of application, the largest application is Livestock Vaccines, followed by Companion Animals Vaccines.
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine Adjuvants.
Report Scope
The Veterinary Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SEPPIC
SDA BIO
Croda
SPI Pharma
Phibro Animal Health
Vertellus
Segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Segment by Application
Livestock Vaccines
Companion Animals Vaccines
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Veterinary Vaccine Adjuvants Market Overview
1.1 Product Overview and Scope of Veterinary Vaccine Adjuvants
1.2 Veterinary Vaccine Adjuvants Segment by Type
1.2.1 Global Veterinary Vaccine Adjuvants Market Value Comparison by Type (2024-2030)
1.2.2 Emulsion Adjuvants
1.2.3 Mineral Adjuvants
1.2.4 Others
1.3 Veterinary Vaccine Adjuvants Segment by Application
1.3.1 Global Veterinary Vaccine Adjuvants Market Value by Application: (2024-2030)
1.3.2 Livestock Vaccines
1.3.3 Companion Animals Vaccines
1.4 Global Veterinary Vaccine Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Veterinary Vaccine Adjuvants Revenue 2019-2030
1.4.2 Global Veterinary Vaccine Adjuvants Sales 2019-2030
1.4.3 Global Veterinary Vaccine Adjuvants Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Veterinary Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Veterinary Vaccine Adjuvants Sales Market Share by Manufacturers (2019-2024)
2.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Veterinary Vaccine Adjuvants Average Price by Manufacturers (2019-2024)
2.4 Global Veterinary Vaccine Adjuvants Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Vaccine Adjuvants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Vaccine Adjuvants, Product Type & Application
2.7 Veterinary Vaccine Adjuvants Market Competitive Situation and Trends
2.7.1 Veterinary Vaccine Adjuvants Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Vaccine Adjuvants Players Market Share by Revenue
2.7.3 Global Veterinary Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Vaccine Adjuvants Retrospective Market Scenario by Region
3.1 Global Veterinary Vaccine Adjuvants Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Veterinary Vaccine Adjuvants Global Veterinary Vaccine Adjuvants Sales by Region: 2019-2030
3.2.1 Global Veterinary Vaccine Adjuvants Sales by Region: 2019-2024
3.2.2 Global Veterinary Vaccine Adjuvants Sales by Region: 2025-2030
3.3 Global Veterinary Vaccine Adjuvants Global Veterinary Vaccine Adjuvants Revenue by Region: 2019-2030
3.3.1 Global Veterinary Vaccine Adjuvants Revenue by Region: 2019-2024
3.3.2 Global Veterinary Vaccine Adjuvants Revenue by Region: 2025-2030
3.4 North America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 North America Veterinary Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Veterinary Vaccine Adjuvants Sales by Country (2019-2030)
3.4.3 North America Veterinary Vaccine Adjuvants Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.5.1 Europe Veterinary Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Veterinary Vaccine Adjuvants Sales by Country (2019-2030)
3.5.3 Europe Veterinary Vaccine Adjuvants Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Veterinary Vaccine Adjuvants Sales by Country (2019-2030)
3.6.3 Asia Pacific Veterinary Vaccine Adjuvants Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Latin America Veterinary Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Veterinary Vaccine Adjuvants Sales by Country (2019-2030)
3.7.3 Latin America Veterinary Vaccine Adjuvants Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2019-2030)
3.8.3 Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Veterinary Vaccine Adjuvants Sales by Type (2019-2030)
4.1.1 Global Veterinary Vaccine Adjuvants Sales by Type (2019-2024)
4.1.2 Global Veterinary Vaccine Adjuvants Sales by Type (2025-2030)
4.1.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2019-2030)
4.2 Global Veterinary Vaccine Adjuvants Revenue by Type (2019-2030)
4.2.1 Global Veterinary Vaccine Adjuvants Revenue by Type (2019-2024)
4.2.2 Global Veterinary Vaccine Adjuvants Revenue by Type (2025-2030)
4.2.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
4.3 Global Veterinary Vaccine Adjuvants Price by Type (2019-2030)
5 Segment by Application
5.1 Global Veterinary Vaccine Adjuvants Sales by Application (2019-2030)
5.1.1 Global Veterinary Vaccine Adjuvants Sales by Application (2019-2024)
5.1.2 Global Veterinary Vaccine Adjuvants Sales by Application (2025-2030)
5.1.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2019-2030)
5.2 Global Veterinary Vaccine Adjuvants Revenue by Application (2019-2030)
5.2.1 Global Veterinary Vaccine Adjuvants Revenue by Application (2019-2024)
5.2.2 Global Veterinary Vaccine Adjuvants Revenue by Application (2025-2030)
5.2.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
5.3 Global Veterinary Vaccine Adjuvants Price by Application (2019-2030)
6 Key Companies Profiled
6.1 SEPPIC
6.1.1 SEPPIC Corporation Information
6.1.2 SEPPIC Description and Business Overview
6.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.1.4 SEPPIC Veterinary Vaccine Adjuvants Product Portfolio
6.1.5 SEPPIC Recent Developments/Updates
6.2 SDA BIO
6.2.1 SDA BIO Corporation Information
6.2.2 SDA BIO Description and Business Overview
6.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.2.4 SDA BIO Veterinary Vaccine Adjuvants Product Portfolio
6.2.5 SDA BIO Recent Developments/Updates
6.3 Croda
6.3.1 Croda Corporation Information
6.3.2 Croda Description and Business Overview
6.3.3 Croda Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Croda Veterinary Vaccine Adjuvants Product Portfolio
6.3.5 Croda Recent Developments/Updates
6.4 SPI Pharma
6.4.1 SPI Pharma Corporation Information
6.4.2 SPI Pharma Description and Business Overview
6.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SPI Pharma Veterinary Vaccine Adjuvants Product Portfolio
6.4.5 SPI Pharma Recent Developments/Updates
6.5 Phibro Animal Health
6.5.1 Phibro Animal Health Corporation Information
6.5.2 Phibro Animal Health Description and Business Overview
6.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Phibro Animal Health Veterinary Vaccine Adjuvants Product Portfolio
6.5.5 Phibro Animal Health Recent Developments/Updates
6.6 Vertellus
6.6.1 Vertellus Corporation Information
6.6.2 Vertellus Description and Business Overview
6.6.3 Vertellus Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Vertellus Veterinary Vaccine Adjuvants Product Portfolio
6.6.5 Vertellus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Vaccine Adjuvants Industry Chain Analysis
7.2 Veterinary Vaccine Adjuvants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Vaccine Adjuvants Production Mode & Process
7.4 Veterinary Vaccine Adjuvants Sales and Marketing
7.4.1 Veterinary Vaccine Adjuvants Sales Channels
7.4.2 Veterinary Vaccine Adjuvants Distributors
7.5 Veterinary Vaccine Adjuvants Customers
8 Veterinary Vaccine Adjuvants Market Dynamics
8.1 Veterinary Vaccine Adjuvants Industry Trends
8.2 Veterinary Vaccine Adjuvants Market Drivers
8.3 Veterinary Vaccine Adjuvants Market Challenges
8.4 Veterinary Vaccine Adjuvants Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
